# Cynthia Aranow

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/cynthia-aranow/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,250 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 72 |
| i10-index | 169 |
| Last Known Institution | Northwell Health |
| OpenAlex ID | https://openalex.org/A5015927371 |
| ORCID iD | 0000-0001-9299-0053 |
| Works | 298 |

## Researcher papers

Showing 12 of 19.

- [Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/derivation-and-validation-of-the-systemic-lupus-international-collaborating/)
- [Vitamin D and the Immune System](https://scholariq.org/papers/vitamin-d-and-the-immune-system/)
- [Mortality in systemic lupus erythematosus](https://scholariq.org/papers/mortality-in-systemic-lupus-erythematosus/)
- [Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis](https://scholariq.org/papers/mycophenolate-mofetil-or-intravenous-cyclophosphamide-for-lupus-nephritis/)
- [The frequency and outcome of lupus nephritis: results from an international inception cohort study](https://scholariq.org/papers/the-frequency-and-outcome-of-lupus-nephritis-results-from-an-international/)
- [Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort](https://scholariq.org/papers/factors-associated-with-damage-accrual-in-patients-with-systemic-lupus/)
- [Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus](https://scholariq.org/papers/belimumab-reduces-autoantibodies-normalizes-low-complement-levels-and-reduces/)
- [2021 DORIS definition of remission in SLE: final recommendations from an international task force](https://scholariq.org/papers/2021-doris-definition-of-remission-in-sle-final-recommendations-from-an/)
- [A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)](https://scholariq.org/papers/a-framework-for-remission-in-sle-consensus-findings-from-a-large-international/)
- [An international cohort study of cancer in systemic lupus erythematosus](https://scholariq.org/papers/an-international-cohort-study-of-cancer-in-systemic-lupus-erythematosus/)
- [Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus](https://scholariq.org/papers/prospective-analysis-of-neuropsychiatric-events-in-an-international-disease/)
- [Cancer risk in systemic lupus: An updated international multi-centre cohort study](https://scholariq.org/papers/cancer-risk-in-systemic-lupus-an-updated-international-multi-centre-cohort-study/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

## Researcher university

- [Northwell Health](https://scholariq.org/institutions/northwell-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.